Your browser doesn't support javascript.
loading
Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan.
Suzuki, Kazuhiro; Namiki, Mikio; Fujimoto, Tsukasa; Takabayashi, Nobuyoshi; Kudou, Kentarou; Akaza, Hideyuki.
Affiliation
  • Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, Gunma kazu@gunma-u.ac.jp.
  • Namiki M; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa.
  • Fujimoto T; Takeda Pharmaceutical Company Limited, Osaka.
  • Takabayashi N; Takeda Pharmaceutical Company Limited, Osaka.
  • Kudou K; Takeda Pharmaceutical Company Limited, Osaka.
  • Akaza H; Department of Strategic Investigation on Comprehensive Cancer Network, The University of Tokyo, Tokyo, Japan.
Jpn J Clin Oncol ; 45(12): 1168-74, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26486824
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Testosterone / Leuprolide / Antineoplastic Agents, Hormonal Type of study: Clinical_trials Limits: Aged / Aged80 / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Testosterone / Leuprolide / Antineoplastic Agents, Hormonal Type of study: Clinical_trials Limits: Aged / Aged80 / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2015 Document type: Article